Healthcare Change and Innovation
This page provides a centralized source for Moody's research on key credit issues relating to healthcare. 
  • Reports
    148 Documents
    03 DEC 2019|Issuer Comment|MOODY'S INVESTORS SERVICE
    A surge in Medicaid costs has doubled New York's projected budget gaps and will require decisive action by the state.
    13 NOV 2019|Sector In-Depth|MOODY'S INVESTORS SERVICE
    The adoption of new or expanded federal healthcare programs would expand the role of the federal government in financing healthcare, but to varying degrees.
    24 OCT 2019|Compilations|Healthcare Quarterly|MOODY'S INVESTORS SERVICE
    Beyond Medicare-for-all: This edition of the Healthcare Quarterly looks at how various political, legislative and regulatory developments will affect the credit of several industry sectors.
    02 OCT 2019|Sector Comment|MOODY'S INVESTORS SERVICE
    Worker's health insurance premiums continue to outpace wages, which is credit negative for the economy and companies, as they weigh on households finances and impede access to healthcare.
    03 SEP 2019|Sector In-Depth|MOODY'S INVESTORS SERVICE
    By canceling higher-rate in-network contracts, UnitedHealth would lower median reimbursement rates in certain geographies — a key benchmark in proposals to curb surprise medical bills.
    03 SEP 2019|Sector Profile|MOODY'S INVESTORS SERVICE
    A detailed report discussing 2018 median not-for-profit healthcare results through a regional lens.
    03 SEP 2019|Sector Profile|MOODY'S INVESTORS SERVICE
    The median growth rate in operating revenues topped expenses for the first time in three years, according to our 2018 medians data for the not-for-profit and public healthcare sector.
    03 SEP 2019|Sector Profile|MOODY'S INVESTORS SERVICE
    The 50 largest and 50 smallest hospitals/healthcare systems diverged as revenue growth eclipsed expense growth for the smallest, but expenses outpaced revenue growth again for the largest.
    07 AUG 2019|Sector In-Depth|MOODY'S INVESTORS SERVICE
    US lawmakers and regulators continue to introduce proposals targeting prescription drug prices – a key social and financial risk for the pharmacuetical industry.
    29 JUL 2019|Sector Comment|MOODY'S INVESTORS SERVICE
    While progress has been gradual, emerging technologies like telehealth, artificial intelligence and big data have significant potential to benefit select physician staffing companies.